Vistagen TherapeuticsVTGN

13F holders, Q2 2025 (June 30)
51holders +3
6new positions
3sold out
1famous investor
$1.95avg. 13F price*

At the end of Q2 2025, 51 institutions reported holding Vistagen Therapeutics Inc. (VTGN) in their 13F filings, up 3 from Q1 2025. 6 opened new positions and 3 sold out. The largest holders were TCG Crossover Management, LLC ($5.4M), Stempoint Capital LP ($4.1M) and Nantahala Capital Management, LLC ($4.0M). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).

Company
Vistagen Therapeutics Inc.
CUSIP
92840H400
Latest filing quarter
Q2 2026

History

Number of 13F holders

0204060 Q1 2024: 41Q1 2024Q2 2024: 42Q2 2024Q3 2024: 47Q3 2024Q4 2024: 54Q4 2024Q1 2025: 48Q1 2025Q2 2025: 51Q2 2025Q3 2025: 58Q3 2025Q4 2025: 55Q4 2025Q1 2026: 56Q1 2026Q2 2026: 48Q2 2026

Total Exit/New Position Q1 2025 → Q2 2025

InstitutionsTotal Value
New Positions6$348K
Exits3$94K

All 13F filers, Q1 2025 → Q2 2025: 412,213 shares bought and 862,039 shares sold, net −449,826 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 51 holders

TCG Crossover Management, LLC 0.61% No change 2,676,580 $5.4M
Stempoint Capital LP 1.33% Add +2.0% 2,413,254 $4.1M
Nantahala Capital Management, LLC 0.28% No change 1,978,492 $4.0M
Vanguard Group Inc. 0.00% Reduce -10.2% 1,759,642 $3.5M
Commodore Capital LP 0.22% No change 1,575,000 $3.1M
JPMorgan Chase & Co. 0.00% Reduce -0.3% 748,862 $1.5M
Ikarian Capital, LLC 0.40% No change 601,703 $1.2M
Sphera Funds Management LTD. 0.23% Reduce -43.3% 447,939 $896K
ADAR1 Capital Management, LLC 0.14% No change 420,765 $842K
BlackRock, Inc. 0.00% Add +0.1% 416,889 $834K
Diadema Partners LP 0.50% Reduce -28.6% 403,922 $808K
Geode Capital Management, LLC 0.00% Add +1.0% 272,907 $546K
Almitas Capital LLC 0.13% Add +2.6% 261,399 $523K
AdvisorShares Investments LLC 0.07% Add +27.6% 203,114 $406K
Boothbay Fund Management, LLC 0.01% No change 177,858 $356K
BML Capital Management, LLC 0.23% No change 150,000 $300K
Susquehanna International Group, LLP 0.00% Add +78.1% 115,368 $231K
State Street Corp. 0.00% No change 96,858 $194K
Jane Street Group, LLC 0.00% New 95,051 $190K
Two Sigma Investments, LP 0.00% Reduce -20.5% 89,451 $179K
Persistent Asset Partners Ltd 0.15% Reduce -28.6% 86,819 $174K
Blair William & Co. 0.00% Reduce -14.9% 85,866 $172K
Northern Trust Corp. 0.00% No change 48,093 $96K
Dimensional Fund Advisors LP 0.00% Add +147.2% 43,362 $87K
Renaissance Technologies 0.00% Add +63.3% 40,500 $81K
Marshall Wace, LLP 0.00% New 34,638 $69K
American Century Companies Inc. 0.00% No change 31,063 $62K
Two Sigma Advisers, LP 0.00% Add +140.7% 25,832 $52K
Charles Schwab Investment Management Inc. 0.00% No change 23,302 $47K
Virtu Financial LLC 0.00% New 22,946 $46K
UBS Group AG 0.00% Reduce -11.5% 22,813 $46K
Simplex Trading, LLC 0.00% Add +838.2% 22,536 $45K
HighTower Advisors, LLC 0.00% No change 20,828 $42K
Kestra Advisory Services, LLC 0.00% No change 20,033 $40K
Morgan Stanley 0.00% Reduce -76.3% 12,147 $24K
Tower Research Capital LLC (TRC) 0.00% New 7,721 $15K
Truvestments Capital LLC 0.00% New 7,155 $14K
Group One Trading LLC 0.00% Add +28.3% 7,142 $14K
Raymond James Financial Inc. 0.00% New 6,410 $13K
Osaic Holdings, Inc. 0.00% Reduce -18.2% 4,493 $9K
Citigroup Inc. 0.00% Add +117866.7% 3,539 $7K
Royal Bank of Canada 0.00% Add +261.9% 3,297 $7K
Bank of America Corp. 0.00% Add +399.0% 3,378 $7K
Performa Ltd (US), LLC 0.00% No change 1,000 $2K
MAI Capital Management 0.00% Reduce -8.7% 526 $1K
Cwm, LLC 0.00% Reduce -63.2% 582 $1K
BNP Paribas Financial Markets 0.00% Add +1.5% 478 $956
SBI Securities Co., Ltd. 0.00% Add +0.7% 288 $576
Jones Financial Companies LLLP 0.00% Add +42.5% 114 $225
Fairman Group, LLC 0.00% No change 29 $58
Barclays PLC 0.00% No change 1 $2

"% of holder's portfolio" is VTGN's weight in each manager's 13F, not the share of Vistagen Therapeutics Inc. the manager owns.